Fig. 2.

Effects of KHG26700 on NF-κB (A), NLRP3 (B), and Iκb-α (C) in LPS-treated BV-2 cells, as determined by immunofluorescence assays and western blot analysis. BV-2 cells were treated with KHG26700 for 30 min followed by treatment with LPS (1 μg/ml) for 24 h. Images presented are from a single experiment and are representative of three independent experiments. β-Actin was used as a loading control. Scale bars were 10 μm in (A) and 50 μm in (B).